Opinion: Antagonism to mRNA Technology Is Killing Our Best Shot At a Cure For Cancer
The recent announcement of RFK Jr.’s termination of mRNA vaccine contracts is the latest effort to undermine this promising technology at the federal level. Pharmaceutical companies and private investors must fill the gap and ensure that research into this critical resource continues.Read more:
biospace.comBiotechnology